RAC 1.11% $1.83 race oncology ltd

Title 40: Cancer Drug TrialCirca: 31 March 2022Description: WIN...

  1. 161 Posts.
    lightbulb Created with Sketch. 574
    Title 40: Cancer Drug Trial
    Circa: 31 March 2022
    Description: WIN News interviews Daniel and Prof Marie Ranson at the University of Wollongong where they discuss the collaboration between Race Oncology and UoW. They explain the efforts being undertaken to refine Zantrene into more versatile formulations - first peripheral IV, and ultimately into an oral pill form. (brief article)
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.